"Ascension St. John Hospital Great Lakes Cancer Management Specialists at Van Elslander Cancer Center in Grosse Pointe Woods, Michigan, are hematologists - oncologists. We listen to understand your questions and concerns and provide answers to your questions about your type of cancer. Then we deliver a care plan. From cancer-fighting treatments and infusion chemotherapy to our support programs, our medical oncologists and oncology-certified nurses are dedicated to helping you defeat cancer. We also have offices in Macomb, Warren, Rochester Hill and provide infusion therapy services at Ascension St. John River District Hospital in East China, Michigan."

During the past decade, Great Lakes Cancer Management Specialists-Van Elslander Cancer Center conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 32 clinical trials were completed, i.e. on average, 26.2% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 32 clinical trials were completed. i.e. 55.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 65 trials, followed by "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "SWOG Cancer Research Network" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Stage IVA Lung Cancer AJCC v8" (8 trials), "Stage IVB Lung Cancer AJCC v8" (8 trials), "Recurrent Lung Non-Small Cell Carcinoma" (7 trials) and "Stage IIIB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center" in a lesser frequency.

Most popular intervention types in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center" are "Drug" (109 trials), "Other" (80 trials), "Biological" (54 trials), "Procedure" (39 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (41 trials), "Laboratory Biomarker Analysis" (29 trials), "Questionnaire Administration" (27 trials), "Computed Tomography" (26 trials) and "Biospecimen Collection" (25 trials). Other intervention names were less common.

The vast majority of trials in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center" are 122 trials for "All" genders, 15 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Great Lakes Cancer Management Specialists-Van Elslander Cancer Center". undefined are not yet recruiting, 53 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, 5 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, 2 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".